Pathophysiologic basis of surgery for Parkinson's disease

Neurology

Volumn 55, Issue 12 SUPPL. 6, 2000, Pages

  Obeso, J A ^a   Rodriguez Oroz, M C ^a   Rodriguez, M ^a   Macias, R ^a   Alvarez, L ^a   Guridi, J ^a   Vitek, J ^a   DeLong, M R ^a  

^a UNIVERSITY CLINIC OF NAVARRA   (Spain)

Author keywords

Basal ganglia; Parkinson's disease; Pathophysiology; Stereotactic surgery

Indexed keywords

ARTICLE; BASAL GANGLION; BRADYKINESIA; BRAIN DEPTH STIMULATION; GLOBUS PALLIDUS; NERVE PROJECTION; PARKINSON DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RIGIDITY; STEREOTAXIC SURGERY; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TREMOR;

BASAL GANGLIA; HUMANS; PARKINSON DISEASE;

EID: 0034719052     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (61)

1. Primate models of movement disorders of basal ganglia origin
2. The functional anatomy of basal ganglia disorders
3. Dopamine differentially regulates dynorphin, substance P, and enkephalin in striatal neurons: In situ hybridization histochemical analysis
4. Primate models of dyskinesia: The experimental approach to the study of basal ganglia-related involuntary movement disorders
5. The current model of basal ganglia organization under scrutiny
6. Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states
7. Basal ganglia and movements disorders: An update
8. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism
9. Basal ganglia pathophysiology. A critical review
10. Functional and pathophysiological models of basal ganglia
11. Pathophysiological considerations in basal ganglia surgery: Role of the basal ganglia in hypokinetic and hyperkinetic movement disorders
12. Physiology of hypokinetic and hyperkinetic movement disorders: Model for dyskinesia
13. Neuronal recordings in Parkinson's disease patients with dyskinesias induced by apomorphine
14. Impaired activation of the supplementary motor area in Parkinson's disease is reversed when akinesia is treated with apomorphine
15. Cortical motor overactivation in parkinsonian patients with L-dopa induced peakdose dyskinesia
16. Restoration of thalamocortical activity after posterovental pallidotomy for Parkinson's disease
17. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease
18. The effects of posteroventral pallidotomy on the preparation and execution of voluntary hand and arm movements in Parkinson's disease
19. Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease
20. Neural mechanisms underlying parkinsonian symptoms based upon regional uptake of 2-deoxyglucose in monkeys exposed to 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine
21. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding
22. Physiology of hypokinetic and hyperkinetic movement disorders: Model for dyskinesia
23. A hypothesis on the pathophysiological mechanisms that underlie levodopa or dopamine agonist-induced dyskinesia in Parkinson's disease
24. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism
25. Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase (GAD) messenger RNA in the pallidum
26. Consequence of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: An in situ hybridization study of cytochrome oxidase subunit I mRNA
27. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia
28. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus
29. Lesion of subthalamic nucleus for the alleviation of MPTP-induced parkinsonism in the primate
30. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis
31. Local inactivation of the sensorimotor territories of the internal segment of the globus and the subthalamic nucleus alleviates parkinsonian motor signs in MPTP treated monkeys
32. Convection-enhanced selective excitotoxic ablation of the neurons of the globus pallidus internus for treatment of parkinsonism in nonhumans primates
33. Treatment of advanced Parkinson's disease by unilateral posterior GPi pallidotomy: 4-year results of a pilot study
34. Long-term follow-up of unilateral pallidotomy in advanced Parkinson's disease
35. Stereotactic targeting of the globus pallidus internus in Parkinson's disease: Imaging versus electrophysiological mapping
36. Somatotopic organization and physiology of the subthalamic nucleus in Parkinson's disease
37. Microelectrode-guided pallidotomy: Technical approach and application for medically intractable Parkinson's disease
38. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease
39. Stimulation of the globus pallidus internus
40. Levodopa withdrawal after bilateral subthalamic nucleus stimulation in advanced Parkinson's disease
41. Organization of the basal ganglia: The importance of axonal collaterization
42. Excitotoxic lesions of the pedunculopontine tegmental nucleus produce contralateral hemiparkinsonism in the monkey
43. The role of the subthalamic nucleus in the origin of hemiballism and parkinsonism: New surgical perspectives
44. Basal ganglia motor control. III. Pallidal ablation: Normal reaction time, muscal cocontraction and slow movement
45. The behavioral and motor consequences of focal lesions of the basal ganglia in man
46. Analysis of choreoid hyperkinesia in the rhesus monkey: Surgical and pharmacological analysis of hyperkinesia resulting from lesions in the subthalamic nucleus of Luys
47. Pallidotomy for hemiballismus efficacy and characteristics of neuronal activity
48. Basal ganglia of patients with dystonia and hemiballismus
49. Levodopa-induced dyskinesia and thalamotomy
50. Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: Problems with the current model
51. Physiologic basis of dyskinesia
52. Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesia
53. Preventing levodopa-induced dyskinesia
54. Functional model of the basal ganglia. Where are we?
55. Multiple output channels in the basal ganglia
56. Dual somatotopical representations in the primate subthalamic nucleus: Evidence for ordered but reversed body-map transformations from the primary motor cortex and the supplementary motor area
57. Basal ganglia and cerebellar loops: Motor and cognitive circuits
58. The subthalamic nucleus and the external pallidum: Two tightly interconnected structures that control the output of the basal ganglia in the monkey
59. Pathophysiology of the basal ganglia in Parkinson's disease
60. The functions of the basal ganglia and the paradox of sterotaxic surgery in Parkinson's disease
61. The subthalamic nucleus, hemiballismus and Parkinson's disease: Reappraisal of a neurosurgical dogma